Endometrial miR-181a and miR-98 are aberrantly expressed in endometrial tumors [44], and miR-181a plays a critical role in epithelial ovarian cancer (EOC) progression through the regulation of the epithelial-mesenchymal transition by modulating the TGF-β signaling pathway [45]. The gene discussed is TGFB1; the disease is endometrium neoplasm.